26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
In Dorman v. Charles Schwab Corp., No. 18-15281 (August 20, 2019), the Ninth Circuit Court of Appeal...
Read More >
When the news broke Friday afternoon that Labor Secretary Alexander Acosta would be resigning from h...
Read More >
A federal judge just extended the reprieve that permitted California employers to escape the grasp o...
Read More >
Climate-related disclosures for asset managers and FCA-regulated pension schemes: FCA correspondence...
Read More >
If January's minimum wage, tip, and overtime developments forecast what employers should expect thro...
Read More >
As employers are well aware, the pay and hours worked data component of the EEO-1 (known as “Compon...
Read More >